Global Interventional Radiology Products Market Size By Type (Stents, Catheters), By Application (Oncology, Cardiology), By Region, And Segment Forecasts, 2023 to 2032

The Global Interventional Radiology Products Market was valued at USD 9.2 billion in 2023 and is projected to reach USD 16.7 billion by 2031, growing at a CAGR of 7.5% during the forecast period from 2023 to 2031. The market's growth is fueled by the increasing incidence of chronic diseases such as cardiovascular disorders, cancer, and peripheral vascular conditions that require minimally invasive diagnostic and therapeutic procedures. Interventional radiology products, including catheters, stents, guidewires, and embolization devices, offer high precision and reduced recovery times, leading to their rising adoption across hospitals and diagnostic centers worldwide.

Drivers

1. Increasing Prevalence of Chronic Diseases:

The rise in lifestyle-related illnesses and an aging global population are major contributors to the growing demand for interventional radiology procedures, which are less invasive alternatives to surgery.

2. Technological Advancements:

The continuous innovation in image-guided techniques, real-time navigation systems, and high-performance devices is significantly enhancing the effectiveness and safety of interventional radiology, further driving adoption.

3. Rising Preference for Minimally Invasive Surgeries:

Interventional radiology offers advantages such as lower infection risk, reduced hospital stays, and quicker recovery times. These benefits are boosting its popularity among both patients and healthcare providers.

Restraints

1. High Equipment Costs:

Advanced interventional radiology equipment involves significant upfront and maintenance costs, which may hinder its adoption, particularly in low-income and underdeveloped regions.

2. Regulatory and Reimbursement Challenges:

Complex regulatory approvals and variations in reimbursement policies across different countries can limit market penetration and slow down innovation uptake.

Opportunity

1. Emerging Markets:

Countries in Asia-Pacific and Latin America are rapidly improving their healthcare infrastructure, opening new avenues for interventional radiology product manufacturers to expand their footprint.

2. Integration with Artificial Intelligence (AI):

The use of AI in diagnostics and navigation during procedures offers potential to enhance precision, reduce human error, and personalize treatment—presenting growth opportunities for future-ready companies.

Market by System Type Insights

The Embolization Products segment led the market in 2023 due to its growing usage in oncology and uterine fibroid treatment. These products play a vital role in stopping bleeding and shrinking tumors non-surgically. Meanwhile, Stents and Catheters are expected to witness strong growth owing to their essential use in cardiovascular and urological interventions.

Market by End-use Insights

Hospitals emerged as the largest end-use segment in 2023, accounting for over 50% of the market. Hospitals are the primary sites for complex interventional radiology procedures, supported by the availability of skilled professionals and advanced imaging infrastructure. Diagnostic Centers are also gaining momentum due to the rise in outpatient procedures and increasing preference for less costly alternatives to hospital-based care.

Market by Regional Insights

North America held the largest market share in 2023, driven by a well-developed healthcare system, high healthcare expenditure, and a strong presence of key players. However, Asia-Pacific is poised to register the highest growth during the forecast period due to increasing healthcare investments, rising patient awareness, and growing disease burden in countries like China and India.

Competitive Scenario

Prominent players in the market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Becton, Dickinson and Company (BD), Cook Medical, Cardinal Health, Siemens Healthineers, Canon Medical Systems Corporation, GE HealthCare, and Philips Healthcare. These companies are actively engaging in strategic partnerships, new product development, and geographical expansion. Notable developments include:

2023: Boston Scientific launched an advanced drug-eluting stent designed for peripheral artery disease.

2024: Philips introduced an AI-integrated imaging system to enhance procedural accuracy in complex interventions.

2025: Medtronic announced collaboration with a leading academic institute to develop robotic-assisted interventional radiology platforms.

Scope of Work – Global Interventional Radiology Products Market

Report Metric Details

Market Size (2023) USD 9.2 billion

Projected Market Size (2031) USD 16.7 billion

CAGR (2023–2031) 7.5%

Market Segments By System Type (Stents, Catheters, Embolization Products, Needles), By End-use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)

Growth Drivers Increasing prevalence of chronic diseases, demand for minimally invasive surgeries, technological advancements

Opportunities AI integration, expansion in emerging economies

Key Market Developments

2023: Terumo Corporation unveiled a next-gen microcatheter for neurointerventional procedures.

2024: BD acquired a niche catheter technology firm to enhance its vascular access portfolio.

2025: Canon Medical launched an AI-enabled angiography system aimed at improving procedural workflow and patient outcomes.

FAQs

1) What is the current market size of the Global Interventional Radiology Products Market?

The market was valued at USD 9.2 billion in 2023.

2) What is the major growth driver of the Global Interventional Radiology Products Market?

The major growth driver is the rising prevalence of chronic diseases and the shift towards minimally invasive surgical procedures.

3) Which is the largest region during the forecast period in the Global Interventional Radiology Products Market?

North America currently holds the largest market share, but Asia-Pacific is expected to grow the fastest.

4) Which segment accounted for the largest market share in Global Interventional Radiology Products Market?

The Embolization Products segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Interventional Radiology Products Market?

Key players include Boston Scientific, Medtronic, Terumo, BD, Cook Medical, Cardinal Health, Siemens Healthineers, GE HealthCare, Canon Medical Systems, and Philips Healthcare.